Impacts of metastatic colorectal cancer (mCRC) on patient health-related quality of life (HRQoL): Results of an online US patient survey.

Authors

Kim Newcomer

Kimberley Lynn Newcomer

Colorectal Cancer Alliance, Washington, DC

Kimberley Lynn Newcomer , Khadijah Ameen , David Fenstermacher , Andrea Incudine , Julie Clauer , Kathy Steinberg , Amy Mulvey , Ashley Geiger , Ashley V. Calabrese

Organizations

Colorectal Cancer Alliance, Washington, DC, BLKHLTH, Atlanta, GA, Family Reach, Boston, MA, COLONTOWN/PALTOWN, Crownsville, MD, Harris Poll, Chicago, IL, Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA

Research Funding

Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA

Background: Effects of disease symptoms and treatment negatively impact the HRQoL of patients (pts) with mCRC, including physical and psychological well-being. Understanding challenges faced by pts with mCRC may help improve HRQoL and enhance their disease journey. Using an online survey, we aimed to gain insights into the effects of mCRC on HRQoL. Methods: Pts aged ≥18 yrs with stage IV colon, rectal, or colorectal cancer participated in an online survey conducted in the US by The Harris Poll between 01/17/24-02/07/24. Of the 344 pts who participated, 254 were recruited via online panels and 90 via pt advocacy groups (PAGs; BLKHLTH, COLONTOWN, Colorectal Cancer Alliance, and Family Reach). The 60-question survey explored the pt profile, diagnosis experience, the role of PAGs/other resources, HRQoL, access to care and financial challenges, discrimination, and treatment experience. Raw data were not weighted and thus are only representative of participants who completed the survey. Sample data are accurate to within 5.3 %-points using a 95% confidence level; all surveys are subject to multiple sources of error. Results: Of 344 participants, 190 (55%) were male, mean age was 56 yrs (±13 yrs); the majority were White (n=158 46%), Black/African American (n=87 25%), or Hispanic (n=75 22%). Of applicable respondents, a majority reported that mCRC had a negative impact on maintaining a normal work schedule (69%), financial wellbeing (69%), emotional wellbeing (67%), hobbies (64%), physical activity (63%), and romantic relationships (61%). However, 43% of applicable pts reported a positive impact on relationships with family and friends, while 70% of overall respondents agreed that a diagnosis had inspired them to act on things they’ve always wanted to do or have pushed off. From an emotional perspective, most pts agreed that they felt like a burden to family (72%) or sensed decreasing support over time from family/friends (63%). Although for many pts a diagnosis had brought them closer to loved ones, 78% agreed they had at times felt alone in their experience, and 70% struggled with being emotionally present. Further, among 330 (96%) pts who had attempted to access mental health resources, 55% had found this difficult, especially Black pts compared to Hispanic and White pts (Table). Conclusions: During their disease journey, pts with mCRC suffer a deterioration in multiple aspects of HRQoL that affects their daily lives, including emotional/mental wellbeing. Better support, specifically improving ease of access to mental health resources, is needed to help pts maintain HRQoL throughout their disease journey.

Ease of access to mental health resources for Black, Hispanic, and White pts.

Ease of access, %All patients n=330Black patients n=85Hispanic patients n=75White patients n=146
Very difficult21271519
Somewhat difficult35362439
Somewhat easy26164125
Very easy18202017

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2024 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Palliative and Supportive Care

Sub Track

Integrating Patient Experience Assessment and Patient Reported Outcomes Into Practice

Citation

JCO Oncol Pract 20, 2024 (suppl 10; abstr 242)

DOI

10.1200/OP.2024.20.10_suppl.242

Abstract #

242

Poster Bd #

D12

Abstract Disclosures

Similar Abstracts

Abstract

2023 ASCO Quality Care Symposium

Racial/ethnic disparities in colorectal cancer screening methods: Unveiling patterns and implications.

First Author: Joy Li

Abstract

2018 ASCO Annual Meeting

Paradoxical survival of Hispanics with colorectal cancer: SEER-based cohort.

First Author: Mahmoud Chaker

Abstract

2022 ASCO Quality Care Symposium

Surviving colorectal cancer: A study of information needs and health-related quality of life.

First Author: Lynette Hammond Gerido